NCT00732641 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Peginterferon α-2b 35 μg, weekly, subcutaneous (SC), until disease progression or relapse, or for up to a maximum of 5 years.
- id
- FG000
- title
- Peginterferon α-2b
- description
- Participants were observed and received no treatment
- id
- FG001
- title
- No Treatment
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 65
- group Id
- FG001
- num Subjects
- 101
- type
- Relapse or Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 12
- group Id
- FG001
- num Subjects
- 3
- type
- Serious Adverse Events
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 0
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 1
- type
- Unable to Complete
- reasons
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 5
- type
- Other
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 123
- group Id
- FG001
- num Subjects
- 121
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- group Id
- FG001
- num Subjects
- 9
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 106
- group Id
- FG001
- num Subjects
- 112
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Peginterferon α-2b 35 μg, weekly, subcutaneous (SC), until disease progression or relapse, or for up to a maximum of 5 years.
- id
- FG000
- title
- Peginterferon α-2b
- description
- Participants were observed and received no treatment
- id
- FG001
- title
- No Treatment
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 65
- group Id
- FG001
- num Subjects
- 101
- type
- Relapse or Progressive Disease
- reasons
- group Id
- FG000
- num Subjects
- 12
- group Id
- FG001
- num Subjects
- 3
- type
- Serious Adverse Events
- reasons
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 0
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 1
- type
- Unable to Complete
- reasons
- group Id
- FG000
- num Subjects
- 18
- group Id
- FG001
- num Subjects
- 5
- type
- Other
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 123
- group Id
- FG001
- num Subjects
- 121
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 17
- group Id
- FG001
- num Subjects
- 9
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 106
- group Id
- FG001
- num Subjects
- 112
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle